PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF INFECTIOUS RESPIRATORY DISEASES CAUSED BY INFLUENZA AND SARS-COV-2, AMONG OTHERS

The present invention relates to a pharmaceutical composition for nasal delivery comprising a co-amorphous compound of curcumin and arginine for use in the treatment of infectious respiratory diseases and airborne diseases such as the respiratory infection caused by SARS-CoV-2, influenza virus, resp...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: BARRANCO HERNANDEZ, GUSTAVO, SENOSIAIN ARROYO, HECTOR
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention relates to a pharmaceutical composition for nasal delivery comprising a co-amorphous compound of curcumin and arginine for use in the treatment of infectious respiratory diseases and airborne diseases such as the respiratory infection caused by SARS-CoV-2, influenza virus, respiratory sincitial virus and adenovirus, among others. L'invention concerne une composition comprenant de la curcumine et de l'arginine, destinée à être utilisée dans le traitement de l'infection respiratoire causée par le SARS-CoV-2, par administration nasale.